Samsung Biologics to Acquire PolyPeptide for CHF 1.46B
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
CRANBURY, New Jersey / SUZHOU, China | July 9, 2026 Porton Advanced, a leading Advanced Therapy Medicinal Products (ATMP)...
HEBEI, China | July 9, 2026 WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has...
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
SEATTLE, June 30, 2026 AGC Biologics has announced a strategic partnership with Pyramid Pharma Services to expand its U.S.-based...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvecâ„¢, a next-generation multimodal viral vector platform designed to...
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
TOKYO and KYOTO, Japan, June 16, 2026 Fujifilm Corporation and HORIBA Ltd. announced the co-development of a high-sensitivity inline...
SILICON VALLEY, Calif. & BEIJING, June 1, 2026 Haisco Pharmaceutical Group Co., Ltd. has announced a landmark licensing and...
